Fluid Biomed Gains $27M in Series A Funding for Brain Stent
Calgary-based Fluid Biomed Inc. Company has raised USD 27 million in a Series A round to further the opportunities for the field-changing flow-diverting brain stent. The stent for the treatment of brain aneurysms is viewed as one of the major innovations in the industry of medical devices.
Visit: https://nextdigitalhealth.com/funding-news/fluid-biomed-gains-27m-in-series-a-funding-for-brain-stent/
#healthcare #funding #healthcarefunding #brainaneurysms #medicaldevices #fluidbiomed
Calgary-based Fluid Biomed Inc. Company has raised USD 27 million in a Series A round to further the opportunities for the field-changing flow-diverting brain stent. The stent for the treatment of brain aneurysms is viewed as one of the major innovations in the industry of medical devices.
Visit: https://nextdigitalhealth.com/funding-news/fluid-biomed-gains-27m-in-series-a-funding-for-brain-stent/
#healthcare #funding #healthcarefunding #brainaneurysms #medicaldevices #fluidbiomed
Fluid Biomed Gains $27M in Series A Funding for Brain Stent
Calgary-based Fluid Biomed Inc. Company has raised USD 27 million in a Series A round to further the opportunities for the field-changing flow-diverting brain stent. The stent for the treatment of brain aneurysms is viewed as one of the major innovations in the industry of medical devices.
Visit: https://nextdigitalhealth.com/funding-news/fluid-biomed-gains-27m-in-series-a-funding-for-brain-stent/
#healthcare #funding #healthcarefunding #brainaneurysms #medicaldevices #fluidbiomed